- Trials with a EudraCT protocol (14,202)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14,202 result(s) found for: Blood Test.
Displaying page 218 of 711.
EudraCT Number: 2004-004575-11 | Sponsor Protocol Number: A6431079 | Start Date*: 2005-01-27 |
Sponsor Name:Pfizer Health AB | ||
Full Title: PERCEPTION AND TOLERABILITY OF NICOTINE FILMS FOR USE IN THE MOUTH. A RANDOMIZED, CROSSOVER, PHASE-II, STUDY IN HEALTHY SMOKERS. | ||
Medical condition: Tobacco dependence | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-021887-13 | Sponsor Protocol Number: NL32588.075.10 | Start Date*: 2010-11-04 | |||||||||||
Sponsor Name:Isala Clinics Zwolle | |||||||||||||
Full Title: Detection of stress in newborns during intubation by means of skin conductance measurements. | |||||||||||||
Medical condition: respiratory insufficiency | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001094-15 | Sponsor Protocol Number: CDBC1 | Start Date*: 2006-09-04 |
Sponsor Name:Oxford Radcliffe Hospitals NHS Trust (Cancer Research UK Medical Oncology Unit, Churchill Hospital) | ||
Full Title: Dose-banding of carboplatin: Effect on area under the plasma concentration - time curve (AUC) compared with individualised dosing | ||
Medical condition: Conditions for which carboplatin is indicated for: 1. Advanced ovarian carcinoma of epithelial origin in: - first line therapy - second line therapy, after other treatments have failed. 2. Small ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-002354-30 | Sponsor Protocol Number: ATS K019 / D-Pio-109 | Start Date*: 2006-07-27 |
Sponsor Name:Takeda Pharma GmbH | ||
Full Title: Effect of Acute Insulin Intervention followed by Pioglitazone and Metformin Treatment on Metabolic Parameters in Type 2 Diabetic Patients with inadequate Metabolic Control | ||
Medical condition: Diabetes Type 2 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-003016-30 | Sponsor Protocol Number: A6431076 | Start Date*: 2005-01-04 |
Sponsor Name:Pfizer Health AB | ||
Full Title: PHARMACOKINETICS OF NICOTINE FILM FOR USE IN THE MOUTH. A RANDOMIZED, CROSSOVER, PHASE-I, COMPARATIVE STUDY IN HEALTHY SMOKERS. | ||
Medical condition: Tobacco dependence | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004065-41 | Sponsor Protocol Number: AML01 | Start Date*: 2013-02-04 |
Sponsor Name:Erasmus Medical Centre | ||
Full Title: Comparative study of pharmacokinetics of amlodipine besilate oral liquid and tablets in healthy Dutch volunteers | ||
Medical condition: Hypertension | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-000904-14 | Sponsor Protocol Number: MICA_HDF | Start Date*: 2012-07-19 | |||||||||||
Sponsor Name:Medizinische Universität Wien | |||||||||||||
Full Title: PHARMACOKINETICS OF MICAFUNGIN DURING CONTINUOUS VENOVENOUS HEMOFILTRATION | |||||||||||||
Medical condition: Suspected or proven candida infection requiring parenteral antifungal therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002260-10 | Sponsor Protocol Number: MCL-metoprolol-IR | Start Date*: 2013-07-11 |
Sponsor Name:Medisch Centrum Leeuwarden | ||
Full Title: The effect of Roux-en-Y gastric bypass on the rate and extent of absorption of metoprolol from an immediate release tablet in female bariatric patient volunteers: a single oral dose study before an... | ||
Medical condition: Roux-en-Y gastric bypass | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-006123-37 | Sponsor Protocol Number: SI-C-019 | Start Date*: 2012-06-06 | |||||||||||
Sponsor Name:Solvotrin Innovations Ltd | |||||||||||||
Full Title: Impact of Eplerenone on Asymptomatic Left Ventricular Diastolic Dysfunction in Diabetic Patients | |||||||||||||
Medical condition: Asymptomatic left ventricular diastolic dysfunction in diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-005809-65 | Sponsor Protocol Number: UA12 | Start Date*: 2006-12-20 |
Sponsor Name:Department of pharmacy, Uppsala University | ||
Full Title: An open, fixed order, single center pharmacokinetic study of the influence of St John's wort on the pharmacokinetics and metabolism of fiansteride in healthy male subjects | ||
Medical condition: The trial contains only healthy volunteers. The indication for Proscar is benign prostatic hyperplasia and for Movina mild depression. | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-003693-14 | Sponsor Protocol Number: IMR2005-007 | Start Date*: 2006-04-03 |
Sponsor Name:Chiesi farmaceutici S.p.A. | ||
Full Title: In-vivo deposition of formoterol after inhalation of a single dose of Formoterol HFA- MDI (Chiesi), and Foradil P inhalation powder (Novartis) in COPD patients. | ||
Medical condition: The study is focused on chronic obstructive pulmonary disease (COPD) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-006148-69 | Sponsor Protocol Number: AIC001-2-001 | Start Date*: 2007-03-06 |
Sponsor Name:AiCuris GmbH & Co. KG | ||
Full Title: Phase 2a Randomized, Controlled, Multi-center, Open-label Dose Ranging Proof of Concept Study to Evaluate the Safety, Tolerability and Antiviral Activity of AIC-001 Over 14 Days of Dosing in Patien... | ||
Medical condition: Pre-emptive treatment for Human cytomegalovirus (HCMV) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004271-22 | Sponsor Protocol Number: INSIGHTPROTOCOL006 | Start Date*: 2015-02-25 | |||||||||||
Sponsor Name:Regents of the University of Minnesota | |||||||||||||
Full Title: Anti-Influenza Hyperimmune Intravenous Immunoglobulin Clinical Outcome Study (INSIGHT 006: FLU-IVIG) | |||||||||||||
Medical condition: Infleunza | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DK (Completed) ES (Completed) GR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003574-28 | Sponsor Protocol Number: THYTECH1-2018-005 | Start Date*: 2019-11-26 |
Sponsor Name:Rafael Correa Rocha | ||
Full Title: Phase I / II clinical trial, randomized, exploratory and prospective to evaluate the safety and efficacy of the transfusion of autologous TREG cells obtained from thymic tissue in the prevention of... | ||
Medical condition: To evaluate the efficacy in the prevention of the rejection of the transfusion of autologous thyTreg cells in children transplanted from the heart | ||
Disease: | ||
Population Age: Newborns, Infants and toddlers, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2005-004430-41 | Sponsor Protocol Number: SSAT 013 | Start Date*: 2005-11-04 |
Sponsor Name:St Stephen's AIDS Trust | ||
Full Title: Effect of food on the pharmacokinetic profile of saquinavir at steady state in HIV-infected patients treated with saquinavir/ritonavir 1000/100 mg b.i.d. | ||
Medical condition: HIV | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002886-38 | Sponsor Protocol Number: 0506 | Start Date*: 2008-08-21 |
Sponsor Name:Faculty of Medicine, Technische Universitaet Muenchen | ||
Full Title: A Multicenter Study on Regenerative Effects of Erythropoitin (LDE) in Burn and Scaled Injuries | ||
Medical condition: Reepidermalization of Split Skin Donor Sites at the lateral upper thigh | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2004-000383-27 | Sponsor Protocol Number: D1803C00002 | Start Date*: 2004-07-28 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A double-blind randomized placebo controlled crossover study of AZD7371 ER 5 mg bid, 20 mg bid and placebo treatment for one week on visceral perception and symptoms in patients with Irritable Bowe... | ||
Medical condition: Irritable Bowel Syndrome (IBS) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-002580-85 | Sponsor Protocol Number: 3d | Start Date*: 2005-08-08 |
Sponsor Name:Rigshospitalet | ||
Full Title: Acute haemodynanic effects of Treatment with ACE inhibitores in patients with severe Aortic Stenosis | ||
Medical condition: Aortic valve stenosis is a reduction of the aortic valve orifice to a degree where emptying of the left ventricule is compromised. The two major causes for aortic valve stenosis is calcific valve d... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000231-95 | Sponsor Protocol Number: TAGUSG6 | Start Date*: 2006-02-13 | |||||||||||
Sponsor Name:IST - ISTITUTO NAZIONALE PER LA RICERCA SUL CANCRO | |||||||||||||
Full Title: A PHASE II STUDY OF BAY 43-9006 IN COMBINATION WITH WEEKLY GEMCITABINE FOR THE TREATMENT OF METASTATIC RCC EITHER UNSUITABLE FOR OR REFRACTORY TO PRIOR TREATMENT WITH CYTOKINES | |||||||||||||
Medical condition: METASTATIC RENAL CANCER CELL | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-005700-14 | Sponsor Protocol Number: IPR/13 | Start Date*: 2006-12-29 | |||||||||||
Sponsor Name:MOLMED | |||||||||||||
Full Title: NGR007 A phase II study of NGR-hTNF administered as single agent every 3 weeks in patients affected by advanced or metastatic small cell lung carcinoma SCLC previously treated with no more than ... | |||||||||||||
Medical condition: patients affected by advanced or metastatic small cell lung carcinoma SCLC previously treated with no more than one therapeutic regimen | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
